Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12
Phase 23
Phase 31

Trial Status

Recruiting3
Other1

Role Distribution

Principal Investigator4
PI Rate100%

Activity Timeline

Clinical Trials (4)

NCT07357298Phase 3Recruiting
Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer
Breast Cancer
PrincipalinvestigatorStart date: 2026-02-25
NCT06238921Phase 1/2Recruiting
Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases
Breast CancerTriple Negative Breast Cancer
PrincipalinvestigatorStart date: 2024-12-19
NCT05528133Phase 2Recruiting
Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer
Triple Negative Breast Cancer
PrincipalinvestigatorStart date: 2023-01-25
NCT04588545Phase 1/2Active Not Recruiting
Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease
HER2-positive Breast CancerLeptomeningeal DiseaseLeptomeningeal Metastasis
PrincipalinvestigatorStart date: 2020-12-10

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Publications (0)

No publications found for this investigator.

Clinical Trials (4)

Showing 4 of 4 trials

NCT07357298Phase 3PrincipalInvestigator

Phase III Trial of Brain MRI Surveillance in Stage IV Breast Cancer

Breast Cancer
Recruiting
NCT06238921Phase 1/2PrincipalInvestigator

Sacituzumab Govitecan and Zimberelimab w/SRS in the Management of Metastatic Triple Negative Breast Cancer With Brain Metastases

Breast CancerTriple Negative Breast Cancer
Recruiting
NCT05528133Phase 2PrincipalInvestigator

Genomically Guided Radiation Therapy in the Management of Triple Negative Breast Cancer

Triple Negative Breast Cancer
Recruiting
NCT04588545Phase 1/2PrincipalInvestigator

Radiation Therapy Followed by Intrathecal Trastuzumab/Pertuzumab in HER2+ Breast Leptomeningeal Disease

HER2-positive Breast CancerLeptomeningeal DiseaseLeptomeningeal Metastasis
Active Not Recruiting

All 4 trials loaded